Abstract
We developed several adenoviral vectors designed to target MDA-7 expression to different subcellular compartments [endoplasmic reticulum (ER), mitochondria, nucleus, and cytosol] and evaluated their ability to enhance apoptosis. Adenoviral ER-targeted mda-7/interleukin-24 vector (Ad-ER-mda7) selectively and effectively inhibited the growth and proliferation of lung (A549 and H1299) and esophageal (Seg1 and Bic1) cancer cells by enhancing cell killing. Both Ad-mda7 and Ad-ER-mda7 activated a novel pathway of ER stress-induced apoptosis characterized by unregulated expression of phosphorylated JNK, phosphorylated c-Jun, and phosphorylated RNA-dependent protein kinase. Caspase-4 activation mediated Ad-mda7- and Ad-ER-mda7-induced cell death. In addition, Ad-mda7- and Ad-ER-mda7-mediated growth inhibition correlated with activation of ER molecular markers RNA-dependent protein kinase and JNK both in vitro (in Ad-mda7- or Ad-ER-mda7-treated lung cancer cells) and in vivo. These findings suggest that vectors targeting the ER (Ad-ER-mda7) may be more effective in cancer gene therapy possibly through more effective induction or ER stress pathways.
References
Dec 8, 1998·The EMBO Journal·S BalachandranG N Barber
Apr 27, 1999·The International Journal of Biochemistry & Cell Biology·R JagusG N Barber
Feb 15, 2001·Gene Therapy·T SaekiR Ramesh
Apr 21, 2001·Cell Death and Differentiation·G N Barber
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L DumoutierJ C Renauld
Dec 26, 2001·Science's STKE : Signal Transduction Knowledge Environment·B R Williams
Apr 4, 2002·Trends in Immunology·Helmut FickenscherHeinrich Sticht
Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eva G CaudellElizabeth A Grimm
Jun 27, 2002·Oncogene·Tomoyuki SaekiRajagopal Ramesh
Mar 10, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kerry A SiegerSunil Chada
May 4, 2004·International Immunopharmacology·Rahul V GopalkrishnanPaul B Fisher
May 4, 2004·International Immunopharmacology·Sunil ChadaAbner M Mhashilkar
Nov 27, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunil ChadaSuhendan Ekmekcioglu
Apr 19, 2005·Cancer Research·Began GopalanRajagopal Ramesh
Apr 27, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Abujiang PataerStephen G Swisher
Apr 27, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sunil ChadaMingzhong Zheng
Dec 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·R KimS Murakami
Jan 7, 2006·Cell Death and Differentiation·J Wu, R J Kaufman
Aug 17, 2006·Cancer Research·Pankaj GuptaPaul B Fisher
Citations
Jul 23, 2013·Cell Death & Disease·J S CarewS T Nawrocki
Feb 2, 2013·Cancer Gene Therapy·P LamB-A Guinn
Nov 23, 2013·Cancer Gene Therapy·Z ZhangM Tagawa
Jan 18, 2014·Cancer Gene Therapy·G MaM Tagawa
Feb 2, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Chengcheng GuoApar Pataer
Oct 12, 2010·Cytokine & Growth Factor Reviews·Rupesh DashPaul B Fisher
Feb 9, 2010·Trends in Molecular Medicine·Stefan Grimm, Mathieu Noteborn
Nov 6, 2014·Oncology Reports·Qunfeng MaHong Jiang
Sep 27, 2019·Oncogene·Apar PataerStephen G Swisher
Oct 23, 2016·Oncotarget·Chuncheng HaoApar Pataer
Oct 16, 2015·Oncotarget·You-Jun LiYaacov Ben-David
Jul 7, 2020·Frontiers in Oncology·Ahmed E M ElhassannyRukiyah Van Dross
Apr 24, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Baobiao ZhuoYingchun Shi